EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

‘When Lightning Strikes Twice’—Preimplantation Genetic Testing for Two Indications in One Biopsy

Einav Kremer, Hagit Daum, Amy Solnica, Tamar Krisher, Assaf Ben Meir, Efrat Esh-Broder, Mali Ketzinel Gilad, Talya Daniel Mordechai, Tal Imbar iD

Prenatal Diagnosis · 2025

DOI: 10.1002/pd.6779 ↗

At a glance

Journal article in Prenatal Diagnosis, 2025. Written by Einav Kremer and 8 co-authors. Institution: IVF Unit, Department of Obstetrics and Gynecology, Hadassah Medical Organization and Faculty of Medicine, The Hebrew University, Jerusalem, Israel. Major MEDLINE topics: Preimplantation Diagnosis, Genetic Testing. 14 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

We aimed to investigate whether the clinical pregnancy and live birth rates in women undergoing preimplantation genetic testing for two indications (PGT2) differ from PGT for one autosomal dominant indication (PGT1).

Method

This retrospective cohort study summarizes data from 44 PGT patients treated between 2015 and 2023. Data were divided into PGT2 ( n = 22 patients, 113 treatment cycles) and PGT1 ( n = 22 patients, 108 treatment cycles) groups. Statistical analysis included descriptive statistics, independent t‐tests, Mann‐Whitney U tests, mixed models, and multivariable mixed logistic regressions.

Results

The groups did not differ in clinical pregnancy and live birth rates. PGT2 patients had more fresh embryos per cycle than the PGT1 group (4.84 vs. 3.18 respectively; p = 0.067) and a significantly lower number of frozen embryos after biopsy (0.29 vs. 0.60 respectively; p = 0.037). No difference was found regarding the mean suitable embryos for biopsy. The PGT2 group had fewer embryos to transfer per cycle (1.30 vs.1.89; p = 0.007), yet there was no difference regarding the number of transferred embryos per cycle.

Conclusion

Testing for two genetic indications in one biopsy is feasible yet yields a lower proportion of embryos genetically suitable for transfer but with a similar live birth rate.

Subjects

MeSH terms (MEDLINE)

Preimplantation DiagnosisGenetic TestingHumansFemalePregnancyRetrospective StudiesAdultBiopsyPregnancy RateEmbryo TransferFertilization in VitroLive Birth

Author keywords

cycle parametersgenetic indicationslive birth ratepreimplantation genetic testing

Authors and institutions

  • IVF Unit, Department of Obstetrics and Gynecology, Hadassah Medical Organization and Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
  • Department of Genetics, Hadassah Medical Organization and Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
  • Faculty of Medicine, Henrietta Szold School of Nursing, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.

ORCID profiles: Tal Imbar

Cite

APA

Kremer, E., Daum, H., Solnica, A., Krisher, T., Ben Meir, A., Esh-Broder, E., Gilad, M. K., Mordechai, T. D., & Imbar, T. (2025). ‘When Lightning Strikes Twice’—Preimplantation Genetic Testing for Two Indications in One Biopsy. Prenatal Diagnosis. https://doi.org/10.1002/pd.6779

Vancouver

Kremer E, Daum H, Solnica A, Krisher T, Ben Meir A, Esh-Broder E, et al. ‘When Lightning Strikes Twice’—Preimplantation Genetic Testing for Two Indications in One Biopsy. Prenatal Diagnosis. 2025. doi:10.1002/pd.6779

BibTeX
@article{Kremer2025,
  author = {Kremer, Einav and Daum, Hagit and Solnica, Amy and Krisher, Tamar and Ben Meir, Assaf and Esh-Broder, Efrat and Gilad, Mali Ketzinel and Mordechai, Talya Daniel and Imbar, Tal},
  title = {‘When Lightning Strikes Twice’—Preimplantation Genetic Testing for Two Indications in One Biopsy},
  journal = {Prenatal Diagnosis},
  year = {2025},
  doi = {10.1002/pd.6779}
}
Start for free →